The Obama administration has proposed regulatory changes in payment for Medicare Part B drugs. They’re looking to impose a broad, multi-year change through a demonstration project.
Obama's Medicare Executive Overreach
This "project" will move as many medications as possible from Part B to Part D.
Mostly cancer drugs, other infusion therapy and insulin (where a pump is involved).
CMS newsletter link
https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2016-Fact-sheets-items/2016-03-08.html
Obama's Medicare Executive Overreach
This "project" will move as many medications as possible from Part B to Part D.
Mostly cancer drugs, other infusion therapy and insulin (where a pump is involved).
CMS newsletter link
https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2016-Fact-sheets-items/2016-03-08.html